Last edition
News about "Mélanie Joly"
Aspect Biosystems Secures USD 280 Million Canada Partnership for Bioengineered Cell Therapies
Aspect Biosystems secures USD 280 Million partnership with Canada to advance bioengineered cell therapies, accelerating clinical development and expanding biomanufacturing capabilities.
Mélanie Joly | 04/04/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members